Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (1K01AI087724-01, U19-AI057266)
U.S. Public Health Service (UL1 TR000454)
School of Medicine, Emory University (Emory + Children’s Pediatric Center Seed Grant Program)
Thrasher Research Fund (2015 Early Career Award Program)
International Pediatric Research Foundation (International Collaborative Award for Research)
Emory University (Laney Graduate School)
National Institutes of Health (HD052460-01, T32AI074492)
Burroughs Wellcome Fund (Molecules to Mankind Program (M2M))
RTI International (Scientific Stature)
Received: 23 March 2017
Accepted: 12 November 2017
First Online: 28 November 2017
Ethics approval and consent to participate
: The study protocol, consent forms, documents, annual reports, and amendments were reviewed and approved by the Bolivian National Bioethics Committee, Research Ethics Commission (Comisión de Ética de la Investigación - Comité Nacional de Bioética) and by Emory University’s Institutional Review Board (IRB00056127). The study convened a Bolivian scientific advisory board, composed of three Bolivian pediatricians, to provide independent oversight and advocate for study participants. The scientific advisory board met annually 2012–2015 and reviewed all study data, protocol changes, and adverse event and severe adverse event reports. Mothers provided written consent in Spanish or Aymara after explaining the purpose of the study in their own words. The 42 mothers who were minors also needed their parent’s consent.
: Not applicable.
: The authors declare they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.